A lab stain may help doctors spot a tumor called chordoma
Original title: T-Pit is a novel, sensitive biomarker for conventional chordoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was a lab look at stored tumor samples, not yet a standard test doctors use.
The short version
Doctors found that a certain protein shows up in chordoma tumors, which may help them name the tumor correctly.
What was studied. Researchers stained tumor samples to look for two proteins, T-PIT and brachyury. They checked 23 chordoma samples and samples from several other kinds of tumors, such as 29 pituitary tumors and 38 low-grade gliomas.
What they found. All 23 chordoma samples had both proteins. This included 18 first-time tumors and 5 that came back. A type of pituitary tumor had T-PIT but not brachyury. Most other tumor types they checked had neither protein.
What this means, and what it doesn't
What it could mean: This test could help doctors tell chordoma apart from other tumors. It also warns them not to rely on T-PIT alone. A tumor with T-PIT might be a chordoma, not a pituitary tumor. Using both proteins together may lower the chance of a wrong diagnosis.
What it doesn't mean: This is a lab study of tumor samples. It is about naming the tumor, not treating it. It does not offer a new treatment, and it is not a cure. More studies are needed before this becomes a routine test.
Source: PubMed, September 17, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.